We examined the effects of the immunotoxin 260F9 Mab-recombinant ricin
A (developed against human breast carcinoma) on proliferating and con
fluent human corneal epithelium (HCE) cells in vitro. HCE cells derive
d from explants of discarded human donor corneoscleral rims were estab
lished as proliferating and confluent cell cultures, and were exposed
continuously for 7 days to immunotoxin. Final cell counts at day 7, an
d thymidine uptake measured at days 1 and 7 postexposure, showed >95%
suppression of proliferating cells at an immunotoxin concentration of
10 ng/ml, with confluent HCE cells relatively unaffected. This immunot
oxin may prove useful in treatment of proliferative ocular epithelial
diseases such as epithelial downgrowth or squamous cell carcinoma of t
he ocular surface.